Drug Shortage Report for FIORINAL-C 1/4
Report ID | 102895 |
Drug Identification Number | 00176192 |
Brand name | FIORINAL-C 1/4 |
Common or Proper name | acetylsalicylic acid- caffeine-codeine-butabital |
Company Name | ARALEZ PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ACETYLSALICYLIC ACID BUTALBITAL CODEINE PHOSPHATE CAFFEINE |
Strength(s) | 330MG 50MG 15MG 40MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | Bottles of 100 capsules |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-02-19 |
Estimated end date | |
Actual end date | 2020-10-21 |
Shortage status | Resolved |
Updated date | 2020-10-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6733 MISSISSAUGA RD MISSISSAUGA, ONTARIO CANADA L5N 6J5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-10-22 | English | Compare |
v9 | 2020-10-21 | French | Compare |
v8 | 2020-10-21 | English | Compare |
v7 | 2020-08-26 | French | Compare |
v6 | 2020-08-26 | English | Compare |
v5 | 2020-02-20 | French | Compare |
v4 | 2020-02-20 | English | Compare |
v3 | 2020-02-20 | English | Compare |
v2 | 2020-01-09 | French | Compare |
v1 | 2020-01-09 | English | Compare |
Showing 1 to 10 of 10